TrialCell reports. Medicine2026

GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trial.

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.